Lansen Pharmaceutical Holdings Limited

HKEX:0503.HK

1.79 (HKD) • At close November 28, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2022202120202019201820172016201520142013201220112010200920082007
Revenue 65.55854.1854.38654.25756.87289.48494.82493.349116.81795.07493.84474.47558.60747.93237.11924.15
Cost of Revenue 21.26319.77119.20720.92826.60137.59541.04845.38654.34642.83639.4230.08820.17415.49311.0947.695
Gross Profit 44.29534.40935.17933.32930.27151.88953.77647.96362.47152.23854.42444.38738.43332.43926.02516.455
Gross Profit Ratio 0.6760.6350.6470.6140.5320.580.5670.5140.5350.5490.580.5960.6560.6770.7010.681
Reseach & Development Expenses 2.1322.6864.2876.501000000000000
General & Administrative Expenses 9.6312.2247.93515.2615.87512.8317.43212.22813.66111.979.8288.677.0245.5464.2245.247
Selling & Marketing Expenses 19.45817.36615.66818.04217.1130.87329.27927.17633.49727.73331.25824.79620.42918.14314.80910.226
SG&A 29.08829.5923.60333.30232.98543.70346.71139.40447.15839.70341.08633.46627.45323.68919.03315.473
Other Expenses -1.465-1.0560.209-3.4780.1-4.6370000000000
Operating Expenses 29.75528.53423.81229.82429.27443.02845.14935.29644.00137.51138.54330.72125.48122.86918.55514.845
Operating Income 14.1588.7712.8523.959-0.5879.4569.18513.82418.92215.14416.16915.60713.1739.577.471.61
Operating Income Ratio 0.2160.1620.2360.073-0.010.1060.0970.1480.1620.1590.1720.210.2250.20.2010.067
Total Other Income Expenses Net -4.243-6.36678.5514.683-0.1917.589-2.159-9.493-0.854-0.0630.397-0.459-0.388-0.667-1.518-0.774
Income Before Tax 9.9152.40491.40218.6422.0917.0457.0264.33118.06815.08116.56615.14812.7858.9035.9520.836
Income Before Tax Ratio 0.1510.0441.6810.3440.0370.190.0740.0460.1550.1590.1770.2030.2180.1860.160.035
Income Tax Expense 1.3181.5013.1970.2931.931.4163.192.264.0883.392.5682.6952.5721.5230.8790.404
Net Income 8.5970.90388.20518.3490.1615.6293.8362.07113.9811.69113.99812.45310.2137.385.0730.432
Net Income Ratio 0.1310.0171.6220.3380.0030.1750.040.0220.120.1230.1490.1670.1740.1540.1370.018
EPS 0.0210.0020.210.04400.0360.0090.0050.0330.0270.0330.0290.0260.0240.0160.001
EPS Diluted 0.0210.0020.210.04400.0360.0090.0050.0330.0270.0330.0290.0260.0240.0160.001
EBITDA 15.25811.6618.4129.1816.01914.33114.08619.38624.35819.17819.73517.24414.28210.4828.2812.083
EBITDA Ratio 0.2330.2150.3390.1690.1060.160.1490.2080.2090.2020.210.2320.2440.2190.2230.086